Compare DUOL & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOL | QGEN |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | 2021 | 1996 |
| Metric | DUOL | QGEN |
|---|---|---|
| Price | $198.16 | $45.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $330.67 | $50.68 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.31% |
| EPS Growth | ★ 338.81 | 331.20 |
| EPS | ★ 8.04 | 1.84 |
| Revenue | $964,271,000.00 | ★ $2,070,781,000.00 |
| Revenue This Year | $40.50 | $7.12 |
| Revenue Next Year | $22.65 | $6.13 |
| P/E Ratio | $26.02 | ★ $24.94 |
| Revenue Growth | ★ 39.86 | 5.32 |
| 52 Week Low | $166.27 | $37.63 |
| 52 Week High | $544.93 | $51.88 |
| Indicator | DUOL | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 44.32 | 47.17 |
| Support Level | $181.20 | $45.55 |
| Resistance Level | $213.37 | $47.48 |
| Average True Range (ATR) | 9.73 | 0.66 |
| MACD | 7.36 | -0.07 |
| Stochastic Oscillator | 67.32 | 24.10 |
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).